Teavitus

Saatja: [email protected] <[email protected]> Saaja: [email protected] Teema: Fifth meeting of Directors-General of Member State health ministries on the revision of pharmaceutical legislation - 10 May 2023 Dear Sir / Dear Madam, It is with pleasure that we announce the adoption on 26 April 2023 of the pharmaceutical package, in which the reform of the EU pharmaceutical legislation is included. We would like to take the opportunity to thank the Member States representatives for their active and helpful role in this process. On this occasion and following our previous successful meetings, our Director-General Ms Sandra Gallina would like to present the content of this reform and have an informal discussion based on the legal proposals with colleagues from the national health ministries at the level of Director-General (DGs). This will be extremely conducive in view of the upcoming steps of the legislative process, namely the discussions in Council and Parliament. To this end, we would like to invite the DGs of national health ministries to join a Webex meeting on Wednesday the 10th of May 2023 from 8:30 to 10:00 CET. Our discussion will be based on the following agenda: * Opening and presentation of the pharmaceutical reform by Sandra Gallina (DG SANTE) * Q&A and discussion * A.O.B. With kind regards, Unit “Medicines: policy, authorisation and monitoring“ [logo-ce-horizontal-en-quadri-jpg24] European Commission DG Health and Food Safety _____________ This message represents solely the views of its author and cannot be regarded as the official position of the Commission. It is intended solely for the person to whom it is addressed and may contain confidential information. If you have received this message in error, please notify me as soon as possible. Ref. Ares(2023)2981968 - 27/04/2023 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY The Director-General Brussels SANTE.DDG1.D.1/AR/am(2023)4490154 NOTE TO THE PERMANENT REPRESENTATIONS OF THE MEMBER STATES TO THE EUROPEAN UNION Dear Sir / Dear Madam, Subject: Fifth meeting of Directors-General of Member State health ministries on the revision of pharmaceutical legislation It is with pleasure that I announce the adoption on 26 April 2023 of the pharmaceutical package, in which the reform of the EU pharmaceutical legislation is included. I would like to take the opportunity to thank the Member States representatives for their active and helpful role in this process. You may access the whole package through the DG SANTE dedicated web page (1). On this occasion and following our previous successful meetings, I would like to present the content of this reform and have an informal discussion based on the legal proposals with colleagues from the national health ministries at the level of Director-General (DGs). This will be extremely conducive in view of the upcoming steps of the legislative process, namely the discussions in Council and Parliament. To this end, I would like to invite the DGs of national health ministries to join a Webex meeting on Wednesday the 10th of May 2023 from 8:30 to 10:00 CET. Our discussion will be based on the following agenda: - Opening and presentation of the pharmaceutical reform by Sandra Gallina (DG SANTE) - Q&A and discussion - A.O.B. There will be no interpretation provided. All participants are requested to proceed with registration through the AGM (Advanced Gateway Meetings) system to be able to receive connection details. (1) https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe/reform-eu- pharmaceutical-legislation_en Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111 E-mail: [email protected]  I kindly ask the Member State permanent representations to forward this invitation to the intended recipients so that they may reserve the space in their calendars. Finally, I kindly ask that participants confirm their attendance to SANTE-PHARMA- [email protected] by Wednesday, 3 May 2023 COB in order to receive further updates and connection details directly. Yours sincerely, [e-signed] Sandra GALLINA Enclosure: Privacy Statement c.c.: Mr J.F. Ryan, Ms M. Moya Diaz, Ms O. Solomon, Mr S. Giraud, Ms R. Ardeleanu, Ms A. Bolufer (DG SANTE) Electronically signed on 26/04/2023 22:50 (UTC+02) in accordance with Article 11 of Commission Decision (EU) 2021/2121 2 Saatja: Webdesktop <[email protected]> Saadetud: 27.04.2023 18:30 Adressaat: <"SM Info">; <"Elen Ohov"> Koopia: <=?utf-8?Q?Agne_Nettan-Sepp_Br=C3=BCsselis?=> Teema: Webdesktop: Teatakse tervishoiuministeeriumite peadirektorite kohtumisest Manused: 403.pdf; 403-edastamismeil.msg Tere! Edastan Komisjoni kirja. EV AEEL juures reg. number: 10.2-11/403 Reg. kuupäev: 27.04.2023 Sisu: Liikmesriikide tervishoiuministeeriumite peadirektorite kohtumine 10.05.2023 (pharmaceutical legislation) Fifth meeting of Directors-General of Member State health ministries on the revision of pharmaceutical legislation 10.05.2023 -- Heade soovidega Tiiu Noobel sekretär, EV alaline esindus EL juures +32 2227 4337